Multipl Sklerozlu Bireyler İçin İletişim ve Dil Değerlendirme Ölçeği'nin (Communication and Language Assessment Questionnaire for Persons With Multiple Sclerosis-CLAMS) Türkçe Versiyonunun Geçerlik ve Güvenirliğinin Araştırılması
View/ Open
Date
2023-08Author
Şahvelioğlu, Özge
xmlui.dri2xhtml.METS-1.0.item-emb
Acik erisimxmlui.mirage2.itemSummaryView.MetaData
Show full item recordAbstract
Multiple sclerosis is a chronic, neuroinflammatory disease of the central nervous system. Communication and language disorders can be seen in multiple sclerosis. These disorders negatively affect individuals' daily participation and quality of life. When evaluating individuals, using patient-reported outcome measures (PROM) is crucial. This study aims to adapt the Communication and Language Assessment Questionnaire for Persons with Multiple Sclerosis – CLAMS into Turkish, to research its validity and reliability, and to bring it into our language. The study included 216 multiple sclerosis diagnosed and 216 healthy individuals who were aged 18 years and older. For the scale's adaptation process, the translation and cultural adaptation procedure recommended by the World Health Organization (WHO) was administered. After the adaptation of the scale, data were collected from the participants. Clinical and demographic information was collected from the participants, and the Turkish form of CLAMS and the Turkish form of the Montreal Cognitive Assessment were administered to the participants. After the data collection phase was completed, the validity and reliability analyses of the scale were made. Content and construct validity analyses were performed for the validity of the scale, internal consistency (Cronbach's Alpha coefficient), and test-retest method analyses for the scale's consistency over time for reliability. When the study results were examined, it was seen that the Turkish version of CLAMS was a valid and reliable scale. It can be used in clinical applications for communication and language disorders of individuals with multiple sclerosis and in scientific studies for research purposes.